← Leaderboards
Lan Wei-Lapierre
University Of Rochester
$2,515,283
Attributed
$2,515,283
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $542K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,515,283 · 3
By mechanism
R01$1,580,278 · 1
R56$511,505 · 1
R21$423,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Rochester
Same institution · by research overlap
- Benjamin Matthew Segal$9,506,634
- Jun Sun$6,946,260
- Ania C Busza$861,272
- John Bachman$90,536
Others in their field
Other Emerging Leaders on “Neurodegenerative Disorders”
- Hemali Phatnani · New York University School Of Medicine$18,133,462
- Bjorn E Oskarsson · Mayo Clinic Jacksonville$14,441,633
- Afonso C Silva · University Of Pittsburgh At Pittsburgh$12,747,968
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$11,195,609
- James Dale Berry · Brigham And Women'S Hospital$11,004,714
- Frederic Geissmann · Sloan-Kettering Inst Can Research$10,015,052
Research focus
Neurodegenerative DisordersParalysedMotor NeuronsMuscle FunctionNeuron LossNew Therapeutic TargetMitochondriaMotorMouse ModelMuscle Denervation ProcedureExerciseNeuromuscular JunctionAnimalsEffective TherapyAdultGenerationsMitochondrial DysfunctionMolecularAxonDisease ProgressionAmyotrophic Lateral SclerosisMuscleDominant-Negative MutationPathogenesis
Grant awards (9)
Using Mitochondrial Ca2+ Uptake as a Therapeutic Target for ALS$457,949
R01 · FY2025 · NS · contact PI
Using Mitochondrial Ca2+ Uptake as a Therapeutic Target for ALS$73,193
R01 · FY2025 · NS · contact PI
Using mitochondrial Ca2+ uptake as a therapeutic target for ALS$433,968
R01 · FY2024 · NS · contact PI
Using mitochondrial Ca2+ uptake as a therapeutic target for ALS$73,193
R01 · FY2024 · NS · contact PI
Using mitochondrial Ca2+ uptake as a therapeutic target for ALS$479,964
R01 · FY2023 · NS · contact PI
Tissue-specific role of aberrant mitochondrial Ca2+ uptake in respiratory and limb muscle dysfunction in ALS$62,011
R01 · FY2023 · NS · contact PI
Using mitochondrial Ca2+ uptake as a therapeutic target for ALS$511,505
R56 · FY2021 · NS · contact PI
The impact of mitochondrial Ca2+ uptake in skeletal muscle in ALS pathogenesis$231,000
R21 · FY2019 · NS · contact PI
The impact of mitochondrial Ca2+ uptake in skeletal muscle in ALS pathogenesis$192,500
R21 · FY2018 · NS · contact PI